| abstract |
THIS INVENTION REFERS TO THE COMPOUNDS OF THE GENERAL FORMULA I, WHERE GROUPS R1, R2 AND N ARE DEFINED IN ACCORDANCE WITH REIVINDICATION 1, WHICH HAVE VALUABLE PHARMACOLOGICAL PROPERTIES, IN PARTICULAR, THEY ARE FIXED TO GHRELAT O-TRANSLATOR (A ) AND MODULATE YOUR ACTIVITY. THE COMPOUNDS ARE SUITABLE FOR THE TREATMENT AND PREVENTION OF DISEASES THAT MAY BE INFLUENCED BY THIS RECEIVER, SUCH AS METABOLIC DISEASES, IN PARTICULAR, OBESITY. |